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Space flight strongly moderates human immunity but is in general well tolerated. Elucidation of the
mechanisms by which zero gravity interacts with human immunity may provide clues for developing
rational avenues to deal with exaggerated immune responses, e.g. as in autoimmune disease. Using two
sounding rockets and one manned Soyuz launch, the influence of space flight on immunological signal
transduction provoked by lipopolysaccharide (LPS) stimulation was investigated in freshly isolated
peripheral blood monocytes and was compared to samples obtained from on-board centrifuge-loaded 1 g
controls. The effect of microgravity on immunological signal transduction is highly specific, since LPS
dependent Jun-N-terminal kinase activation is impaired in the 0 g condition, while the corresponding LPS
dependent activation of p38 MAP kinase remains unaffected. Thus our results identify Jun-N-terminal
kinase as a relevant target in immunity for microgravity and support using Jun-N-terminal kinase specific
inhibitors for combating autoimmune disease.
T
he constant threat of pathogenic organisms and the resulting evolutionary pressure to develop defences
against these challenges, has resulted in an array of collaborative defensive cell systems. These consist,
amongst others, of phagocytes and adaptive B and T cell systems which are collectively grouped under
the broad denominator immunity. The human immune system, like all cell biological systems in our body, has
developed in the continuous presence of the earth’s gravitational field. Thus it is conceivable that acute absence of
this external force, as occurs during space flight, would influence functionality in this system. Indeed since the
early days of space exploration it has been evident that extra-atmospheric primates and humans experience
reduced immune function1–4. Certainly, some of the observed effects on immune function can be related to
environmental factors such as cosmic radiation5 and magnetic fields6. Furthermore, psychological factors such as
stress and anxiety7 from living and working in a confined space, under cramped conditions and with inadequate
lifestyle, nutritional regimen and disturbance of circadian rhythm8,9 may affect the immune system. Nevertheless,
there are good reasons to believe that the weightlessness itself negatively influences immunocompetence of the
human body10–13. Experimentation with crewmembers of space flights showed reduced anti-viral immunity15 and
a landmark experiment conducted in Spacelab 1 in 1983 demonstrated a near total absence of activation of
peripheral blood leukocytes upon exposure to concanavalin A (Con-A) when compared to identical ground
controls4. The mechanistic basis of this effect however, remains largely obscure. A recent study employing DNA
array analysis of Con-A and anti-CD28-stimulated T cells, on board of the international space station, showed
that microgravity-exposed T cells were deficient in transcription of immediate early genes associated with the
tumour necrosis factor alpha pathway. However, T cells stimulated in an on-board centrifuge, artificially gen-
erating a 1 g condition, did not show this effect. And thus the effects of spaceflight on the immune system are
related to microgravity and are indeed not just a mere artefact resulting from stress4,14. The molecular pathways
mediating these effects remain to be elucidated, but their knowledge could provide important clues on how to
device better therapies for conditions associated with exaggerated activation of the immune system on earth, e.g.
autoimmune disease or leukaemia.
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Results
Experimental design. To identify the interaction of the immune
system with spaceflight and microgravity in particular, we decided
to investigate the effect of stimulation of primary isolated human
peripheral blood monocytes with LPS in 0 g versus 1 g conditions
during space flight. LPS is a relatively invariant surface structure of
gram negative bacteria. Its recognition by TLR-4 forms an important
part of the innate immune response16,17 and provokes highly
reproducible responses and signal transduction in peripheral blood
monocytes, which have been characterized in great detail18. To this
end, after appropriate consent, blood was obtained from young
healthy volunteers (aged 22–31) and monocytes were isolated
using Ficoll density gradient centrifugation followed by classical
adherence19. Monocytes were loaded in fully-automated culture
units capable of administrating 100 ng/ml LPS or vehicle control
followed by fixative at predetermined timelines. The loaded units
were then placed in a specially designed module which maintained
the ambient temperature at 37uC. Within the module, units were
either placed on a static rack, permissive of exposing cells to
changes in gravity or on a centrifuge that maintained cells at 1 g
throughout the experiments. For our study we chose to initiate
experimentation 1 min after the onset of microgravity by
application of LPS. Cells were fixed with 4% formaldehyde after
5 min of LPS stimulation, as we have shown previously that this
time point correlates with the most profound LPS-induced changes
in monocyte kinase activity18. Figure 1 schematically shows the setup
and timeline of the experiments involved. In this fashion, the
experiment was executed three times. One time on a manned
Soyuz flight launched from Baikanur in Kazakhstan and two times
on a Maser sounding rocket launched from Esrange in Sweden.
Stimulations were performed within 10 hour after blood was
drawn. After recovery of the module, the material was investigated
for space flight and microgravity-induced effects on LPS-induced
signal transduction.
Activation of p38 map kinase is not affected by space flight-
associated microgravity. One of the most pronounced biochemi-
cal changes following LPS challenge, is the phosphorylation and
thereby activation of p38 MAP kinase20. Inhibition of p38 MAP
kinase protects against endotoxemia in LPS challenged healthy
volunteers21, although clinical implementation of pharmacological
p38 MAP kinase inhibition has not proven viable because of side
effects and excessive vulnerability towards bacterial infection.
Various genes, like PRKCA22, whose expression is known to be
exquisitely sensitive to microgravity are known to be regulated by
p38 MAP kinase23. Hence, it is conceivable that activation of p38
MAPK is impaired during microgravity. As expected, the onboard
1 g control displayed p38 MAP kinase activation (Figure 2). In
contrast, activation of p38 MAP kinase was not impaired in
microgravity-exposed monocytes, if anything p38 MAP kinase
activation appears to be increased. Thereby suggesting that space
flight-associated microgravity does not interfere with LPS-induced
pro-inflammatory signal transduction per se and its effects, if present,
are restricted to specific signaling pathways.
Jun-n-terminal kinase is not activated by lps during space flight-
associated microgravity. In general inflammatory stimuli co-
activate p38 MAP kinase and Jun-N-terminal kinase, as activation
of both kinases displays similar kinetics24. Nevertheless, they are
activated by different upstream kinases (MKK3/6 and MKK4/7 for
p38MAP kinase and Jun-N-terminal kinase, respectively25). Thus, at
Figure 1 | Summary of the experimental procedure and the timeline. The experiment was repeated three times. The first experiment was performed as
part of the 2004 Soyuz TMA-4 campaign. Under the name Kappa it was executed during a manned flight to the International Space Station. The
experiment was repeated in 2005 during theMaser 10mission (Amuse) and again in 2012 during theMaser 12mission (Micimmun). Bothmissions used
sounding rockets to carry the experiment into space. During a parabolic flight the rocket reaches an altitude of approximately 260 km allowing for 5 to 6
minutes of microgravity. The experiments are performed in automated climate chambers termed Flush Units. The Flush Units are placed within the BIM
module. Themodule regulates ambient temperature aboard the rocket and provides electricity to the FlushUnits during flight. As an onboard control the
Flush Units can be placed in a centrifuge which spins at a speed equal to the force of gravity. The other units are placed on a static rack and are allowed to
experience microgravity. Prior to the flight the monocytes are placed inside a rectangular chamber containing two glass slides to which the monocytes
attach. At the start of microgravity a timed mechanism releases a spring plunger which replaces the medium in the culture chamber with medium
containing LPS. At the end of microgravity a similar mechanism replaces the LPS containing mediumwith fixative. We would like to acknowledge NASA
and Dutch Space for the use of their illustrations in this figure.
www.nature.com/scientificreports
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least theoretically, the possibility exists that space flight-associated
microgravity targets Jun-N-terminal kinase without a concomitant
effect on p38 MAP kinase. Surprisingly, during microgravity the
capacity of LPS to stimulate Jun-N-terminal kinase activation is
lost, whereas monocytes stimulated with LPS during the onboard
control condition were completely Jun-N-terminal kinase activa-
tion proficient (Figure 3). Thus, microgravity evokes a dichotomy
in immunological signaling, allowing p38 MAP kinase activation to
proceed, but incompatible with LPS dependent Jun-N-terminal
kinase activation. Although it does not involve immunologically
relevant cells, the observation that the induction of c-Jun in A431
cells by epidermal growth factor is absent in microgravity26, fits well
with our findings. Especially since it has been well established that
Jun-N-terminal kinase is involved in the induction of c-Jun and p38
MAPK is not.
Effects of space flight-associated microgravity on erk activation.
Although less pronounced than the effect on Jun-N-terminal kinase,
an inhibitory influence of microgravity on the capacity of LPS to
provoke activation of the extracellular regulated kinase (ERK) was
observed (Figure 4). This corresponds with recent findings in T cells
that show a minor effect of microgravity on ERK phosphorylation in
unstimulated T cells27. Thus, the effect of microgravity is not solely
restricted to Jun-N-terminal kinase.
Diminished activity of the immune system is among the foremost
effects of space flight on the human body28. Importantly, this dimin-
ished activity of the immune system is well-tolerated. Over forty
years of experience with manned space flight have now conclusively
demonstrated that man can easily survive and work in weightless
conditions, despite chronic repression of the body’s immune func-
tions29. This suggests that mimicking space-related immunosuppres-
sion on earth may be a fairly safe way of suppressing the action of the
immune system. Although experimental requirements allowed for
only 6 minutes of microgravity, there is good evidence that even a
relatively short inhibition of kinases can have a substantial effect on
functionality of the innate immune system30. Therefore we feel that
the observed effect on Jun-N-terminal kinase is relevant to the
explanation of space flight-associated immunosuppression. The
observed dichotomy between p38 MAP kinase and Jun-N-terminal
kinase is consistent with these observations: p38 MAP kinase is
important for fighting immediate bacterial threats and thus its
inhibition causes undesirable side effects in these and other
respects31. On the other hand, Jun-N-terminal kinase is more assoc-
iated with chronic inflammatory responses32,33 whose inhibition
represents a clear and for now unresolved clinical need.
Methods
Microgravity experimentation. This study received Institutional Review Board
approval from the Academic Medical Center and informed consent was obtained in
accordance with the Declaration of Helsinki. The methods were carried out in
accordance with the approved guidelines. Blood was drawn from young healthy
volunteers (health status was ascertained by a physical examination) in Vacutainer
tubes (Becton-Dickinson, Breda, the Netherlands) containing EDTA-K3. Peripheral
blood mononuclear cells (PBMCs) were isolated from peripheral blood of healthy
volunteers using standard density gradient centrifugation over Ficoll-Paque Plus
(Amersham Biosciences AB), followed by washing and resuspension in IMDM
supplemented with 10% fetal bovine serum, penicillin, streptomycin, and
amphotericin. Blood was drawn ten hours before launch time. The experiments were
performed in the ‘‘Biology InMicrogravity’’ flight module that has been developed by
Dutch Space (Leiden, the Netherlands) and the Kubik module developed by ESA
Figure 2 | Microgravity does not influence activation of p38 MAP Kinase following LPS stimulation. The figure shows phospho-p38 MAP kinase
analysis of 100 ng/ml LPS stimulated monocytes in the presence (1 g) or relative absence of gravity (0 g). Fixed monocytes were stained fluorescently
(green) and the nuclei were visualized by DAPI (blue) (Figure 2A). Staining was measured at different exposure times (Figure 2B) andmean fluorescence
was finally determined at 2000 ms (Figure 2D). Although differences between the conditions are apparent, the absence of gravity does not affect activation
of p38 MAP kinase. The nuclear localization of p38 MAPK is also not different from the control condition (Figure 2C). The graphs are based on 36
determinations.
www.nature.com/scientificreports
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Figure 3 | LPS-dependent Jun-N-terminal kinase activation is sensitive to space flight-associated microgravity. The figure shows phospho-Jnk analysis
of LPS stimulatedmonocytes in the presence (1 G) or relative absence of gravity (0 G). Fixedmonocytes were stained fluorescently (green) and the nuclei
were visualized by DAPI (blue) (Figure 3A). Comparison between individual cells clearly shows a brighter staining when stimulated with LPS in the
presence of gravity. Staining intensity was measured at different exposure times (Figure 3B) and mean fluorescence was finally determined at 2000 ms
(Figure 3D). Microgravity significantly impairs the activation of Jnk in monocytes. Analysis of nuclear localization of activated Jnk shows no change
(Figure 3C). The graphs are based on 32 determinations. *P , 0.05.
Figure 4 | Effects of microgravity on ERK activation. The figure shows phospho-Erk analysis of LPS stimulated monocytes in the presence (1 G) or
relative absence of gravity (0 G). Fixed monocytes were stained fluorescently (green) and the nuclei were visualized by DAPI (blue) (Figure 4A).
Comparison between individual cells clearly shows a brighter staining when stimulated with LPS in the presence of gravity. Staining intensity was
measured at different exposure times (Figure 4B) and mean fluorescence was finally determined at 2000 ms (Figure 4D). Microgravity impairs the
activation of Erk inmonocytes. Analysis of nuclear localization of activated Erk shows no change (Figure 4C). The graphs are based on 32 determinations.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 4 : 5468 | DOI: 10.1038/srep05468 4
(Noordwijk, The Netherlands), which were loaded with automated experimental
container units developed by the Centre for Concepts of Mechatronics (Nuenen, The
Netherlands). Launch vehicles were sounding rockets developed by Swedish Space
Corporation (SSC) and the Soyuz-TMA rocket produced through the Russian space
programme. Experiments employed a late access unit, which was installed into the
payload 4 hours before launch. An integrated thermal controller maintained the
experiment temperature at 36.5 6 0.5uC. Monocytes, a 100 ng/ml LPS containing
activation solution and the 4% formaldehyde fixative in PBS were loaded into the
flight hardware. The hardware devices contain two experimental units of which each
unit contains three chambers. The two outer chambers were connected via small
tubes in the lid with themiddle chamber which contained the biological material. The
chambers for the fixative contain special storage compartments, since fixatives for
biological material diffuse easily through rubbers and plastics. Electronically-
controlled springs released activation solution and fixative at pre-set time points, so
that the solutions in the storage chambers are pushed via the connecting tubes into the
reaction chamber. The LPS-containing solution or the vehicle control was transferred
shortly after the onset of microgravity, whereas the fixative was transferred exactly
5 min later. Technical failure was a substantial problem: of the 96 biological
experiments send in space only 31 samples obtained from the Maser 12 flight
qualified for further analysis, limiting the number analyses possible. Realistic
vibration tests with the BIM-2 module were performed at the Environmental Test
Laboratory of Thales Cryogenics (Eindhoven, The Netherlands) during flight
qualification procedures and did not affect experimental outcomes (not shown).
Accelerations of the payload and of the centrifuge were continuously monitored and
recorded during flight.
Analysis of kinase activation. Following recovery, cells were extensively washed with
PBS and permeabilized with PBS containing 0.1% Triton X-100. Subsequently,
samples were incubated overnight at 4uC with anti-phospho-p38 MAPK (pThr180/
pTyr182) monoclonal rabbit antibody, anti-phospho-Jun-N-terminal kinase
(pThr183/pTyr185) monoclonal rabbit antibody or anti-phospho-Erk1/2 (pThr202/
pTyr204) monoclonal rabbit antibody, all obtained from Cell signaling Technology
(http://www.cellsignal.com/) followed by incubation with the secondary antibody
anti-rabbit AlexaFluor488 (Invitrogen, Carlsbad, CA) for 1 h at room temperature
and counterstained with DAPI. Confocal images were obtained on a Leica TCS SP2
system equipped with 405-nm UV, 488-nm argon, and 543-HeNe lasers (Leica,
Mannheim, Germany) and processed using ImageJ (National Institutes of Health,
Bethesda, MD) software for constructing total fluorescence signal and automated
analysis of nuclear versus cytoplasmic signal.
Statistical analysis. Tests for statistical significance of differences were made by
heteroscedastic 2-tailed student t test using the program SPSS 16.0. Differences were
considered significant when p , 0.05.
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